Venture Planning Group, Sep 2011
and sales forecasts by country for HerpesSimplex I/II and Herpes Type VI testing for the following markets: - Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
Venture Planning Group, April 2012, Pages: 241
forecasts by country for HerpesSimplex I/II and Herpes Type VI testing for the following markets:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
For each country
Venture Planning Group, April 2012, Pages: 1900
by Market Segment
France ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
France HerpesSimplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
France Herpes Type VI Test
Venture Planning Group, Feb 2012, Pages: 1037
by Market Segment
France ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
France HerpesSimplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
France Herpes Type VI Test
Venture Planning Group, April 2012, Pages: 980
by Market Segment
France
ALT/SGPT Test Volume and Diagnostics Sales Forecast
by Market Segment
France
HerpesSimplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Herpes Type VI Test
Venture Planning Group, April 2012, Pages: 976
Ag Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market
Segment
Japan
HerpesSimplex I and II Test Volume and Diagnostics
Sales
Venture Planning Group, April 2012, Pages: 970
by Market
Segment
List of Tables (continued)
Italy
ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market
Segment
Italy
HerpesSimplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Venture Planning Group, Sep 2011, Pages: 1900
by Market Segment
France HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
France ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
France HerpesSimplex I and II Test Volume
Venture Planning Group, April 2012, Pages: 983
by Market
Segment
Germany
HerpesSimplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany
Herpes Type VI Test Volume and Diagnostics Sales Forecast by
Market Segment
Germany
Influenza
Venture Planning Group, April 2012, Pages: 960
by Market
Segment
Spain
HBeAg Test Volume and Diagnostics Sales Forecast by Market
Segment
Spain
ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market
Segment
List of Tables (continued)
Spain
HerpesSimplex I
Venture Planning Group, April 2010, Pages: 983
Sales Forecast by Market Segment
Germany
ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
Germany
HerpesSimplex I and II Test Volume and Diagnostics Sales Forecast
TriMark Publications, May 2011, Pages: 3057
, hospital labs and commercial laboratories. Additionally, rapid detection of food pathogens and infectious pathogens (MRSA, herpessimplex, avian flu, West Nile virus and typhoid) are discussed. The report
Venture Planning Group, April 2012, Pages: 978
Forecast by Market
Segment
U.K.
ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
HerpesSimplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K.
Influenza
Venture Planning Group, June 2011, Pages: 1900
Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Table of Contents (continued)
35. Human Herpes Virus-6 (HHV-6)
a. Background
0 HIV-6 Infections
b. Diagnostic Tests
c. Vaccines
TriMark Publications, Feb 2012, Pages: 460
such as rapid detection of food pathogens and infectious diseases (MRSA, herpessimplex, avian flu, West Nile virus and typhoid) are discussed. Growth moderators and developing trends in point of care
Venture Planning Group, June 2011, Pages: 1050
- Hepatitis D (Delta)
O Vaccines and Drugs
* HerpesSimplex Virus
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Legionella
O Background
O Diagnostic Tests
O Vaccines and Drugs
* Lyme Disease
O